Showing results (721-730 of 5,269) with videos related to

Sort By:
Pageof 527
European Journal of Haematology|February 14, 2004
Possible role of cytokine-induced tryptophan degradation in anaemia of inflammationGuenter Weiss, Katharina Schroecksnadel, Verena Mattle, et al.
European Journal of Haematology|February 14, 2004
Clinicopathological correlations of TIMP-1 and TIMP-2 in Hodgkin's lymphomaHeli Pennanen, Outi Kuittinen, Ylermi Soini, et al.
European Journal of Haematology|February 14, 2004
Successful treatment of chemotherapy-refractory Sézary syndrome with alemtuzumab (Campath-1H)O Gautschi, N Blumenthal, M Streit, et al.
European Journal of Haematology|February 14, 2004
Myocardial ischemia in a patient with acute lymphoblastic leukemia during L-asparaginase therapyAlessia Saviola, Mario Luppi, Leonardo Potenza, et al.
European Journal of Haematology|October 2, 2004
Lipoteichoic acid derived from Enterococcus faecalis modulates the functional characteristics of both normal peripheral blood leukocytes and native human acute myelogenous leukemia blastsØystein Bruserud, Øystein Wendelbo, Kristin Paulsen
European Journal of Haematology|October 2, 2004
Cardiac status in well-treated patients with thalassemia majorAthanasios Aessopos, Dimitrios Farmakis, Antonia Hatziliami, et al.
European Journal of Haematology|June 9, 2004
Excessive production of tumor necrosis factor-alpha by bone marrow T lymphocytes is essential in causing bone marrow failure in patients with aplastic anemiaTakeshi Hara, Kazuki Ando, Hisashi Tsurumi, et al.
European Journal of Haematology|July 8, 2005
Etiology of thrombocytopenia in all patients treated with heparin productsDamian A Laber, Monte E Martin
European Journal of Haematology|July 8, 2005
Deoxycoformycin (pentostatin) in the treatment of splenic marginal zone lymphoma (SMZL) with or without villous lymphocytesEmilio Iannitto, Viviana Minardi, Giuseppina Calvaruso, et al.
European Journal of Haematology|March 22, 2005
Markers of endothelial and haemostatic function in the treatment of relapsed myeloma with the immunomodulatory agent Actimid (CC-4047) and their relationship with venous thrombosisMatthew Streetly, Beverley J Hunt, Kiran Parmar, et al.
Pageof 527